Latest News & Features
Big Pharma
The World Health Organization (WHO) has released a study on the public health impact of counterfeit drugs, showing that tens of thousands of children die as a result of the problem every year. 30 November 2017
Europe
The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR. 30 November 2017
Americas
A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe. 30 November 2017
Big Pharma
The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry. 29 November 2017
Americas
A subsidiary of medical technology company Stryker has settled its clash over trade secrets with Zimmer, a medical device business. 29 November 2017
Asia
AstraZeneca and the Chinese Future Industry Investment Fund have partnered to establish a company focused on discovering, developing and commercialising new medicines. 28 November 2017
Big Pharma
Israel-headquartered Teva has announced a series of organisational and leadership changes as it seeks to address external pressures and internal inefficiencies. 28 November 2017
Biotechnology
The EU General Court has annulled a decision by the Community Plant Variety Office, in a dispute between a developer and distributor of sugar beet seeds and an Italy-based company. 27 November 2017
Big Pharma
MSD, known as Merck and Co in the US and Canada, announced plans to launch a life sciences discovery research facility just hours ahead of the UK government’s release of its industrial strategy. 27 November 2017
Big Pharma
The English Court of Appeal today handed down its decision in a dispute between pharmaceutical company Merck Sharp & Dohme (MSD) Corp and its German rival Merck KGaA, offering a mixed ruling. 24 November 2017